Sanofi (SNYNF) Gets a Hold from J.P. Morgan
In a report released today, Richard Vosser from J.P. Morgan maintained a Hold rating on Sanofi, with a price target of €95.00.
Claim 30% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Vosser covers the Healthcare sector, focusing on stocks such as Roche Holding AG, Novo Nordisk, and Sanofi. According to TipRanks, Vosser has an average return of 0.5% and a 45.23% success rate on recommended stocks.
In addition to J.P. Morgan, Sanofi also received a Hold from Bank of America Securities’s Sachin Jain in a report issued today. However, on March 20, Berenberg Bank maintained a Buy rating on Sanofi (Other OTC: SNYNF).
Based on Sanofi’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of €23.74 billion and a net profit of €2 billion. In comparison, last year the company earned a revenue of €11.42 billion and had a net profit of €683 million
Read More on SNYNF:
Disclaimer & DisclosureReport an Issue
- Regeneron, Sanofi get approval for Dupixent to treat bullous pemphigoid in Japan
- Sanofi’s Amlitelimab Eczema Trial Reaches Completion, Setting Up a Key Pipeline Catalyst
- Sanofi initiated with an Outperform at Bernstein
- Trump Trade: President issues short-term waiver of Jones Act
- Trump claims TrumpRx website offers lowest prices, review says not so, NYT says
